JP MORGAN/CALL/ABBOTT LABORATORIES/120/0.1/16.08.24 Share Price

Warrant

DE000JB8EUA0

Market Closed - Börse Stuttgart 07:21:13 25/06/2024 pm IST
0.022 EUR -4.35% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/120/0.1/16.08.24
Current month+15.79%
1 month-31.25%
Date Price Change
25/24/25 0.022 -4.35%
24/24/24 0.023 -37.84%
21/24/21 0.037 +48.00%
20/24/20 0.025 -7.41%
19/24/19 0.027 +17.39%

Delayed Quote Börse Stuttgart

Last update June 25, 2024 at 07:21 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JB8EUA
ISINDE000JB8EUA0
Date issued 18/12/2023
Strike 120 $
Maturity 16/08/2024 (51 Days)
Parity 10 : 1
Emission price 0.38
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.76
Lowest since issue 0.014
Delta0.07x
Omega 26.97
Premium14.68x
Gearing385.19x
Moneyness 0.8740
Difference Strike 15.12 $
Difference Strike %+12.60%
Spread 0.015
Spread %45.45%
Theoretical value 0.0255
Implied Volatility 23.33 %
Total Loss Probability 94.10 %
Intrinsic value 0.000000
Present value 0.0255
Break even 120.27 €
Theta-0.01x
Vega0x
Rho0x

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.9 USD
Average target price
125.2 USD
Spread / Average Target
+19.33%
Consensus